InvestorsHub Logo
Followers 3
Posts 114
Boards Moderated 0
Alias Born 10/02/2017

Re: roctober post# 1502

Wednesday, 10/04/2017 3:04:26 PM

Wednesday, October 04, 2017 3:04:26 PM

Post# of 2001
Yes data should be published and released this month. >80%
New trials for both candidates are being started too. Insane the PPS sits where it does. I firmly believe it benefits Medivir and Tetralogic debt holders by keeping commons in the dark. Again just an opinion.

https://clinicaltrials.gov/ct2/show/NCT03180528?term=Remetinostat&rank=1